Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target.

Oakley, Sebastian S; Maina, Mahmoud B; Marshall, Karen E; Al-Hilaly, Youssra K; Harrington, Charlie R; Wischik, Claude M; Serpell, Louise C

Oakley, Sebastian S; Maina, Mahmoud B; Marshall, Karen E; Al-Hilaly, Youssra K; Harrington, Charlie R; Wischik, Claude M; Serpell, Louise C.

Afiliação

Oakley SS; Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, United Kingdom.
Maina MB; Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, United Kingdom.
Marshall KE; College of Medical Sciences, Yobe State University, Damaturu, Nigeria.
Al-Hilaly YK; Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, United Kingdom.
Harrington CR; Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, United Kingdom.
Wischik CM; Chemistry Department, College of Science, Mustansiriyah University, Baghdad, Iraq.
Serpell LC; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.

Front Neurol ; 11: 590754, 2020.

Article em En | MEDLINE | ID: mdl-33281730

Palavras-chave

Alzheimer's disease; filaments; in vitro models; self-assembly; tau; tau aggregation inhibitors; tauopathies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Neurol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google